H.R. 4509119th CongressIn committeeLatest action Jan 13, 2026Decoded by AI · checked against the record
The plain-language version leads. The official text is always the reference.
HR 4509 forces the VA to add FDA-approved non-opioid surgical pain drugs to its national formulary within one year of approval.
65-second read · 5 questions answered below
HR 4509 would require the Department of Veterans Affairs to add newly FDA-approved non-opioid pain medications to its national formulary within one year, provided those drugs also qualify for special payment status under Medicare rules. The VA would also be required to place these drugs on its standardized drug list to ensure consistent availability across all VA facilities. The VA Secretary would have 90 days from enactment to begin implementing these changes.
The bill primarily affects veterans who receive medical care through the VA, particularly those recovering from surgery who may need alternatives to opioid pain medications. VA facilities and administrators would also be affected, as the bill removes discretion over whether and when to add qualifying non-opioid drugs.
Currently, a veteran's access to a specific pain medication can vary depending on which VA facility they use, and the VA sets its own timeline for adding new drugs. This bill would create a uniform national standard, meaning access to qualifying non-opioid pain treatments would no longer depend on a veteran's location or the VA's independent scheduling decisions.
AI-drafted summary. Verify it against the official text before you act on it. Read the official bill on Congress.gov
Right now: a House committee is reviewing it. If the Senate changes it, it goes back to the House before reaching the President.
Latest action: — Subcommittee Hearings Held